|
Amanda is a beautiful 18 year old girl, diagnosed in October 2001 with Alveolar Soft Part Sarcoma (ASPS), a very rare cancer that feeds off her blood as it grows into deadly sacks. Amanada has the only known case of this type of cancer in Canada and among 20 reported cases internationally. Only one percent of cancers are sarcomas and Amanda's type of cancer in her lungs and thighs is only one percent of all those. Because it is so rare, there has been little research conducted on this type of cancer. Last summer (2001) Amanda found a lump on her thigh. Initially, a clinic doctor dismissed it as natural fatty tissue. It wasn't until the growth was removed and tested in the fall, that it was diagnosed at alveolar soft part sarcoma (ASPS). In December 2001, lumps in Amanda's lungs were removed. But in January 2002, just two weeks after the surgery, the tumours returned to Amanda's lungs. As the family was told by the specialist that it could take 5 to 10 years before a relapse, this was devastating news. And in the midst of her treatments, Amanda lost her grandfather to cancer in April. Amanda
and her family returned to North Bay in erly June as there is a 6 month
limit for families staying at the Ronald McDonald House in Toronto. Amanda
has been participating in a clinical trial which required her to travel
to Sudbury 3 times a week for chemotherapy and once a month to Toronto
for testing. This has been extremely hard not only on Amanda, but also
her family. The grace and the dignity with which Amanda and her family, parents Janette and Mike Minderlein, along with twin brother Matthew, and her 19 year old brother Jeffery, is a testamont to the love this family holds for each other as they have struggled for appropriate access to medical services for Amanda and the survival of their family. This
is an average Canadian family.
If
you are in a position to help Amanda and her family,
ASPS is a malignant soft tissue tumor. Malignant soft tissue tumors are divided by the oncologists into rhabdomyosarcoma and "all others", or "non-rhabdomyosarcomatous". They do this because apparently these two groups behave differently from each other. Rhabdomyosarcoma (of which there are many subtypes, including, confusingly, alveolar rhabdomyosarcoma [don’t mix this up with ASPS – they are completely different]) seems to respond to chemotherapy in a better way than non-rhabdomyosarcomatous tumors. Source
|
||||||
|
Home | Amanda's Story | About Amanda | Contact | ASPS Last Updated August 24, 2002 1:04 pm |
||||||
|
|
||||||